Is there a rationale for the prophylactic prescription of hematopoietic colony-stimulating factor after a bacteriologically documented neutropenic infection?

Authors :: Thieblemont C
Frappaz D
Coullioud D
Fuhrmann C
Bouffet E
Brunat-Mentigny M
Philip T
Source :: Pediatric hematology and oncology [Pediatr Hematol Oncol] 1996 Sep-Oct; Vol. 13 (5), pp. 473-5.
Publication Year :: 1996

Subjects :: Antineoplastic Combined Chemotherapy Protocols adverse effects
Bacterial Infections epidemiology
Bacterial Infections prevention & control
Fever etiology
France epidemiology
Humans
Immunocompromised Host
Incidence
Neoplasms complications
Neoplasms drug therapy
Neutropenia chemically induced
Neutropenia complications
Retrospective Studies
Sepsis etiology
Sepsis prevention & control
Bacterial Infections etiology
Hematopoietic Cell Growth Factors therapeutic use
Neutropenia drug therapy
Sepsis epidemiology

Full Text Access

Tools